Roche’s Digital Pathology Solution Bags the US FDA’s Clearance for its Use in Diagnosis
Shots:
- The US FDA has granted 510(k) clearance to the company’s whole-slide imaging system, the Roche Digital Pathology Dx (VENTANA DP 200), to be utilized in diagnosis
- The system allows pathologists to review and analyze images obtained by scanning pathology slides for patient diagnosis
- Digital pathology is the transformation of traditional histopathology by digitalizing slide scanning, visualization and analysis to enhance the efficiency, analysis depth and collaboration opportunities
Ref: PR Newswire | Image: Roche
Related News:- Roche Reports Data from the P-III Clinical Evaluation of Columvi to Treat R/R Diffuse Large B-cell Lymphoma
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Disha is a content writer at PharmaShots. She is passionate and curious about recent updates and developments in MedTech and Pharma industry. She covers news related to clinical trial results and updates. She can be contacted at connect@pharmashots.com.
